A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation
FASEB JOURNAL
Authors: Kim, Yoon Seong; Choi, Dong Hee; Block, Michelle L.; Lorenzl, Stefan; Yang, Lichuan; Kim, Youn Jung; Sugama, Shuei; Cho, Byung Pil; Hwang, Onyou; Browne, Susan E.; Kim, Soo Yul; Hong, Jau-Shyong; Beal, M. Flint; Joh, Tong H.
Abstract
Recent studies have demonstrated that activated microglia play an important role in dopamine (DA) neuronal degeneration in Parkinson disease (PD) by generating NADPH-oxidase (NADPHO)-derived superoxide. However, the molecular mechanisms that underlie microglial activation in DA cell death are still disputed. We report here that matrix metalloproteinase-3 (MMP-3) was newly induced and activated in stressed DA cells, and the active form of MMP-3 (actMMP-3) was released into the medium. The released actMMP-3, as well as catalytically active recombinant MMP-3 ( cMMP-3) led to microglial activation and superoxide generation in microglia and enhanced DA cell death. cMMP-3 caused DA cell death in mesencephalic neuron-glia mixed culture of wild-type (WT) mice, but this was attenuated in the culture of NADPHO subunit null mice (gp9(1phox-/-)), suggesting that NADPHO mediated the cMMP-3-induced microglial production of superoxide and DA cell death. Furthermore, in the N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)- injected animal model of PD, nigrostriatal DA neuronal degeneration, microglial activation, and superoxide generation were largely attenuated in MMP-3-/- mice. These results indicate that actMMP-3 released from stressed DA neurons is responsible for microglial activation and generation of NADPHO-derived superoxide and eventually enhances nigrostriatal DA neuronal degeneration. Our results could lead to a novel therapeutic approach to PD.
Whole Genome Analysis of the Red-Crowned Crane Provides Insight into Avian Longevity
MOLECULES AND CELLS
Authors: Lee, HyeJin; Kim, Jungeun; Weber, Jessica A.; Chung, Oksung; Cho, Yun Sung; Jho, Sungwoong; Jun, JeHoon; Kim, Hak-Min; Lim, Jeongheui; Choi, Jae-Pil; Jeon, Sungwon; Blazyte, Asta; Edwards, Jeremy S.; Paek, Woon Kee; Bhak, Jong
Abstract
The red-crowned crane (Grus japonensis) is an endangered, large-bodied crane native to East Asia. It is a traditional symbol of longevity and its long lifespan has been confirmed both in captivity and in the wild. Lifespan in birds is known to be positively correlated with body size and negatively correlated with metabolic rate, though the genetic mechanisms for the red-crowned crane's long lifespan have not previously been investigated. Using whole genome sequencing and comparative evolutionary analyses against the grey-crowned crane and other avian genomes, including the long-lived common ostrich, we identified red-crowned crane candidate genes with known associations with longevity. Among these are positively selected genes in metabolism and immunity pathways (NDUFA5, NDUFA8, NUDT12, SOD3, CTH, RPA1, PHAX, HNMT, HS2ST1, PPCDC, PSTK CD8B, GP9, IL-9R, and PTPRC). Our analyses provide genetic evidence for low metabolic rate and longevity, accompanied by possible convergent adaptation signatures among distantly related large and long-lived birds. Finally, we identified low genetic diversity in the red-crowned crane, consistent with its listing as an endangered species, and this genome should provide a useful genetic resource for future conservation studies of this rare and iconic species.